The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 120 pages and 15 tables
SIMILAR MARKET STUDIES
2017 Infectious Disease Testing Instrumentation Review: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-Microbiology Analyzers and Strategic Profiles of Leading Suppliers
This 86-page report reviews major analyzers used for microbiology testing, including their operating characteristics, features and selling prices. The report also presents strategic assessments of leading microbiology market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 86 pages
March 2017 | $0 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Digoxin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory ...
October 2015 | $0 | View Details >>
2016-2020 Ireland Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests-Emerging Opportunities for Instrument and Reagent Suppliers, Competitive Strategies
November 1999 | $0 | View Details >>
Notes: Sales, means the sales volume of Bone Complication Treatment Revenue, means the sales value of Bone Complication Treatment This report studies sales (consumption) of Bone Complication Treatment in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and ...
September 2016 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research